跳至主要内容
临床试验/NCT01990950
NCT01990950已完成不适用

Evaluation of the Long-term Safety and Performance of the Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Post-Approval Study

Cook Research Incorporated6 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2014年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
21
试验地点
6
主要终点
Treatment Success : AAA Related Mortality

研究概览

简要总结

This post-market study is approved by the US FDA to evaluate the long-term safety and performance of the Zenith® Fenestrated AAA Endovascular Graft.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •abdominal aortic and aortoiliac aneursyms with a diameter greater than or equal to 5 cm
  • •aortic or aortoiliac aneurysm with a history of growth greater than or equal to 0.5 cm per year, or clinical indication for AAA repair

排除标准

  • •proximal neck less than 4mm or greater than or equal to 15 mm in length unless otherwise compromised to preclude seal
  • •renal artery stenosis greater than 50 percent

研究组 & 干预措施

Zenith® Fenestrated AAA Endovascular Graft

Experimental

干预措施: Zenith® Fenestrated AAA Endovascular Graft (Device)

结局指标

主要结局

Treatment Success : AAA Related Mortality

时间窗: 5 years

patients treated with the Zenith® Fenestrated AAA Endovascular Graft will have a rate of aneurysm-related mortality at 5 years that meets a performance goal of 18% ,

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验